Literature DB >> 14686490

Dominant beta-thalassemia with hemoglobin Hradec Kralove: enhanced hemolysis in the spleen.

Shouichi Ohga1, Akihiko Nomura, Hidetoshi Takada, Junko Kato, Hiroshi Ideguchi, Yukio Hattori, Masahiro Suda, Sachiyo Suita, Toshiro Hara.   

Abstract

We describe a 6-year-old girl and her mother with dominant beta-thalassemia due to hemoglobin Hradec Kralove (Hb HK). Both patients presented microcytic anemia, jaundice, splenomegaly, cholelithiasis, and recurrent hemolytic bouts. Osmotic resistance tests using saline and coiled planet centrifugation revealed the increased fragility of the red cell membrane. On the other hand, the glycerol lysing time was prolonged, and results of the isopropanol test were weakly positive. Despite mimicking the features of hereditary spherocytosis, the results of the genetic analyses verified the second reported family with Hb HK (codon 115, GCC [Ala] --> GAC [Asp]). Splenectomy was effective for the amelioration of hemolysis. Of 7 reported patients with Hb variants at beta-globin codon 115 (Hb Madrid and Hb HK), 5 underwent splenectomy. Because of the variable augmentation of extramedullary hemolysis in dominant beta-thalassemias, genotyping is necessary for determining the clinical indication of splenectomy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14686490     DOI: 10.1007/BF02983557

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  25 in total

Review 1.  Is it dominantly inherited beta thalassaemia or just a beta-chain variant that is highly unstable?

Authors:  S L Thein
Journal:  Br J Haematol       Date:  1999-10       Impact factor: 6.998

2.  The second case of dominant beta-thalassemia induced by the codon 127 (CAG-->TAG) described as a de novo mutation in a Dutch boy.

Authors:  M Van Weel; C L Harteveld; L F Bernini; T M Brouwers; P C Giordano
Journal:  Hemoglobin       Date:  1999-11       Impact factor: 0.849

Review 3.  Dominant beta thalassaemia: molecular basis and pathophysiology.

Authors:  S L Thein
Journal:  Br J Haematol       Date:  1992-03       Impact factor: 6.998

4.  A single nucleotide deletion in codon 123 of the beta-globin gene causes an inclusion body beta-thalassaemia trait: a novel elongated globin chain beta Makabe.

Authors:  S Fucharoen; Y Kobayashi; G Fucharoen; Y Ohba; K Miyazono; Y Fukumaki; F Takaku
Journal:  Br J Haematol       Date:  1990-07       Impact factor: 6.998

5.  Dominant thalassemia-like phenotypes associated with mutations in exon 3 of the beta-globin gene.

Authors:  H H Kazazian; C E Dowling; R L Hurwitz; M Coleman; A Stopeck; J G Adams
Journal:  Blood       Date:  1992-06-01       Impact factor: 22.113

6.  Enhanced haemolysis with beta-thalassaemia trait due to the unstable beta chain variant, Hb Gunma, accompanied by hereditary elliptocytosis due to protein 4.1 deficiency in a Japanese family.

Authors:  Tadashi Maehara; Norifumi Tsukamoto; Yoshihisa Nojima; Masamitsu Karasawa; Hirokazu Murakami; Yukio Hattori; Hiroshi Ideguchi
Journal:  Br J Haematol       Date:  2002-04       Impact factor: 6.998

7.  Hemoglobin Petah Tikva (alpha 110 ala replaced by asp): a new unstable variant with alpha-thalassemia-like expression.

Authors:  G R Honig; M Shamsuddin; R Zaizov; M Steinherz; I Solar; C Kirschmann
Journal:  Blood       Date:  1981-04       Impact factor: 22.113

8.  A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood.

Authors:  A Eldor; R Durst; E Hy-Am; A Goldfarb; S Gillis; E A Rachmilewitz; A Abramov; J MacLouf; Y C Godefray; E De Raucourt; M C Guillin
Journal:  Br J Haematol       Date:  1999-12       Impact factor: 6.998

9.  Phenotype variability of the dominant beta-thalassemia induced in four Dutch families by the rare cd121 (G-->T) mutation.

Authors:  P C Giordano; C L Harteveld; J J Michiels; W Terpstra; L J Schelfhout; I M Appel; D Batelaan; P van Delft; R J Plug; L F Bernini
Journal:  Ann Hematol       Date:  1998-12       Impact factor: 3.673

10.  Unusually severe heterozygous beta-thalassemia: evidence for an interacting gene affecting globin translation.

Authors:  P J Ho; G W Hall; S Watt; N C West; J W Wimperis; W G Wood; S L Thein
Journal:  Blood       Date:  1998-11-01       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.